StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Ansh Jogendra Bhilwar

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: Intraday13 Oct 2026, 8:00 am ISTvia Zee Business (Live)

Entry₹1,136.1Inferred
Target₹1,166
Total upside +2.63% (call closed)
Stop loss₹1,117-1.68% risk
Exit₹1,11713 Oct 2026, 9:22 am
Stop-loss hit-1.68%
Follow Ansh Jogendra Bhilwar for new calls(17% target hit, 94 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Oct 2026
2 supporting0 opposing
Supports the BUY call (2)

Zydus presented Phase 3 trial data showing improved biochemical response for Saroglitazar compared to placebo.

BSE · Company Update·12 Oct · today

(opens in new tab)

1 advisor has an active swing BUY call on this stock

Advisor consensus · adjacent horizon·29 Sept · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Ansh Jogendra Bhilwar

Every call and its outcome